Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2020 16:24 ET | Source: Akorn, Inc.

Akorn Provides Second Quarter 2020 Results

LAKE FOREST, Ill., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (The OTC Pink Market: AKRXQ), a leading specialty pharmaceutical company, today announced its financial results for the second...
June 22, 2020 17:15 ET | Source: Akorn, Inc.

Akorn Animal Health Announces Launch of Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment

LAKE FOREST, Ill., June 22, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (OTC Pink Market: AKRXQ), a leading specialty generic pharmaceutical company, today announced the launch of its Abbreviated New...
May 11, 2020 17:14 ET | Source: Akorn, Inc.

Akorn Provides First Quarter 2020 Results

LAKE FOREST, Ill., May 11, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the first quarter of 2020. ...
February 26, 2020 16:58 ET | Source: Akorn, Inc.

Akorn Provides Fourth Quarter and Full Year 2019 Results

LAKE FOREST, Ill., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended...
December 16, 2019 07:51 ET | Source: Akorn, Inc.

Akorn Announces Extension of Standstill Agreement

LAKE FOREST, Ill., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that Akorn and certain of its lenders have reached an...
November 05, 2019 19:00 ET | Source: Akorn, Inc.

Akorn to Present at the Credit Suisse Healthcare Conference

LAKE FOREST, Ill., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that management will present at the Credit Suisse 28th...
October 31, 2019 07:00 ET | Source: Akorn, Inc.

Akorn Provides Preliminary Third Quarter 2019 Results

LAKE FOREST, Ill., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its preliminary financial results for the third quarter...
October 14, 2019 16:25 ET | Source: Akorn, Inc.

Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application...
October 14, 2019 13:05 ET | Source: Akorn, Inc.

Akorn to Report Third Quarter 2019 Financial Results and Host Conference Call

LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it plans to issue a press release before market open...
August 26, 2019 13:35 ET | Source: Akorn, Inc.

Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%

LAKE FOREST, Ill., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug...